ID   CGL2
AC   CVCL_C8P1
SY   CGL-2; CGL 2
DR   BTO; BTO:0006503
DR   Wikidata; Q123030905
RX   PubMed=7323948;
RX   PubMed=15471901;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8NZ ! ESH5
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=7323948; DOI=10.1007/BF01538758;
RA   Stanbridge E.J., Flandermeyer R.R., Daniels D.W., Nelson-Rees W.A.;
RT   "Specific chromosome loss associated with the expression of
RT   tumorigenicity in human cell hybrids.";
RL   Somatic Cell Genet. 7:699-712(1981).
//
RX   PubMed=15471901; DOI=10.1093/carcin/bgh295;
RA   Yih L.-H., Hsueh S.-W., Luu W.-S., Chiu T.H., Lee T.-C.;
RT   "Arsenite induces prominent mitotic arrest via inhibition of G2
RT   checkpoint activation in CGL-2 cells.";
RL   Carcinogenesis 26:53-63(2005).
//